ELI LILLY AND CO (LLY) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 100% based on the firm’s underlying fundamentals and the stock’s ...

The biopharmaceutical sector might see some disruptions soon, according to Barclays. This belief comes after a mid-stage ...

Disclosure. None. 14 Dividend Growth Stocks with Highest Growth Rates is originally published on Insider Monkey.

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed results. Eli Lilly’s LLY tirzepatide, ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abbott Labs (ABT – Research Report) and ...

Novo Nordisk (NVO) continues to be rated as a Buy, with the stock already charting an impressive +16.1% rally over the past 3 ...

Eli Lilly and Co. (NYSE:LLY) announced on Wednesday that its popular weight loss drug tirzepatide showed promising results in ...

Eli Lilly (LLY) stock is higher after two-late stage trials showed its weight loss drug Mounjaro helped sleep apnea patients ...